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Abstract
Background: The uterine cervix is a gateway to several non-neoplastic and neoplastic gynecological lesions. Most of 
these non-neoplastic lesions are commonly found in women of reproductive age. These lesions constitute a source of 
morbidity and mortality in women worldwide hence the need to analyze them to provide a baseline data of the pattern 
of these lesions in our local environment.
Objective: The purpose of this study is to determine the frequency and morphological patterns of non-neoplastic cervical 
lesions at the central hospital, Warri, Nigeria.
Materials and Methods: All uterine cervical biopsies received at the Department of Pathology, Central Hospital, Warri 
over a 7 year period (January 2005-December 2011) were the specimens for this study. Slides were retrieved from 
the archives of the Department of Pathology. Where necessary, new sections were made from formalin fixed, paraffin 
embedded blocks.
Results: A total of 176 cervical specimens were received in the Pathology Department during this period. Of these, 
56.3% were benign lesions while 43.7% were malignant. Among the benign cases, non-neoplastic lesions accounted 
for 92.9% of benign cervical lesions. The age range of non-neoplastic cervical lesions was 20 to 89 years with a mean 
age of 54.9 ± 4.6 years. The peak age incidence of non-neoplastic cervical lesion was 40-49 years which accounted for 
33.7%. Inflammatory lesions and tumor-like lesions accounted for 59.8% and 40.2% of non-neoplastic cervical lesions 
respectively. Among the inflammatory lesions, chronic non-specific cervicitis was the most commonly encountered 
lesion constituting 72.2% of all inflammation. Human papilloma virus (HPV) cervicitis with koilocytic changes accounted 
for 14.5% of all inflammatory lesions.
Conclusion: Inflammatory lesions were the most frequent non-neoplastic cervical lesions. These lesions therefore 
account for significant amount of gynecological problems in our environment. Adequate cervical screening with follow 
up histological biopsies is a relevant tool in diagnosing them to enhance early detection of premalignant and malignant 
cervical lesions.
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Introduction
Non‑neoplastic cervical lesions cut across all age groups 
amongst women but are more commonly seen in sexually 
active women. These lesions include inflammatory and 
tumor‑like non‑neoplastic lesions. Majority of non‑neoplastic 
lesions are inflammatory in nature.[1] Inflammatory lesions of 
clinicopathological importance are acute cervicitis, chronic 
cervicitis and chronic granulomatous cervicitis.[1,2] These 
can result from both infective and non‑infective aetiology. 
Infective causes of acute and chronic cervicitis include a wide 
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spectrum ranging from bacterial, viral, protozoan and fungi 
microorganisms commonly encountered in sexually transmitted 
infections (STIs) and urinary tract infections (UTIs). Studies 
have shown that chronic granulomatous cervicitis is mostly 
caused by tuberculosis.[3] Sexual transmitted viruses include 
human papilloma virus (HPV) and herpes simplex virus. HPV 
cervicitis is a causal risk factor for condylomata acuminatum, 
pre‑invasive cervical intraepithelial neoplasia (CIN I, II, III) 
and eventually cervical cancer.[4]
Tumor‑like non‑neoplastic cervical lesions according to 
the World Health Organization include endocervical 
hyperplasia, endometriosis, nabothian cyst, endocervical 
polyps.[5] Study done by Pallipady et al. have shown that 
polypoidal endocervicitis, squamous metaplasia, micro 
glandular hyperplasia, accounted for 29.3%, 73.4%, 2.6% 
of all non‑neoplastic lesions of the cervix respectively.[2]
The aim of this study is to establish the prevalence and 
histological types of non‑neoplastic cervical lesions of the 
cervix in Delta State, Nigeria. It is hoped that data derived 
from this research will be useful in the management of these 
lesions and as well serve baseline data for further research.
Materials and Methods
All uterine cervical biopsies received at the Department 
of Pathology, Central Hospital, Warri over a 7 year period 
from January 2005‑December 2011 were the materials for 
this study. These specimens were sent from the Obstetrics/
Gynecology and Consultant’s out patient clinic of this 
hospital, and other hospitals in the Warri metropolis and all 
over Delta State of Nigeria. Clinical and demographic data 
including age, sex, clinical history, diagnosis was obtained 
from surgical day books, request cards and case files. Slides 
were retrieved from the archives of the Department of 
Pathology. Where necessary new sections were made from 
formalin fixed, paraffin embedded blocks and stained with 
Hematoxylin and Eosin. Where necessary special stains 
were used to further characterize cervical lesions. These 
lesions are classified using the World Health Organization 
(W.H.O.) criteria[5]




During this seven year period, a total of 176 cervical 
specimens were received in the Pathology Department. Of 
these, 99 cases (56.3%) were benign lesions while 77 cases 
(43.7%) were malignant. Among the benign cases, 92 were 
non‑neoplastic accounting for 92.9% of benign cervical 
lesions.
Table 1 shows the age distributions of non‑neoplastic cervical 
lesions. The age range of non‑neoplastic cervical lesions 
was 20 to 89 years with a mean age of 54.9 ± 4.6 years. 
The peak age incidence was 40‑49 years accounting for 
33.7% of non‑neoplastic cases. Only 7 cases (7.6%) and 
5 cases (5.5%) occurred before 30 years and after 70 years 
respectively.
Clinicopathological Analysis
Table 2 shows the histological types of non‑neoplastic 
cervical lesions. Inflammatory lesions accounted for 
55 cases (59.8%) of non‑neoplastic cervical lesions. Thirty 
seven cases (40.2%) were tumor‑like non‑neoplastic 
cervical lesions. Among the inflammatory lesions, 
chronic non‑specific cervicitis was the most commonly 
encountered lesion constituting 40 cases (72.2%) of all 
inflammation. Our study show that 75.2% of all chronic 
non‑specific cervicitis occurred in the 4th to 6th decades 
of life.
Human papilloma virus (HPV) cervicitis with koilocytic 
changes accounted for 14.5% of all inflammatory lesions. 
The second most common lesion was endocervical polyps 
accounting for 15 cases (16.3%) of non‑neoplastic cervical 
lesions. Ectropion with squamous metaplasia was rare 
accounting for 11.1% of non‑neoplastic cervical lesions. 
Endocervical hyperplasia, nabothian cyst, and endometriosis, 
were extremely uncommon lesions accounting for (n = 4; 
Table 1: Age Distribution of Patients with 
Non‑Neoplastic Cervical Lesions









Table 2: Histological Types of Non‑Neoplastic Cervical 
Lesions
Histological Diagnosis Frequency Percentage
Acute cervicitis 7 7.6
Chronic non‑specific cervicitis 40 43.5
Chronic cervicitis with HPV koilocytosis 8 8.7
Ectropion 11 11.9
Endocervical Hyperplasia 4 4.3
Endocervical polyps 15 16.3
Cervical prolapsed 1 1.1
Nabothian cyst 3 3.3
Endometriosis 2 2.2
Granulation Tissue 1 1.1
Total 92 100
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4.3%) (n = 3; 3.3%), and (n = 2; 2.2%) of non‑neoplastic 
cervical lesions respectively.
Discussion
In these 7 years retrospective study 176 histological 
confirmed benign cervical lesions were reported. Of these, 
56.3% were benign and 43.7% were malignant lesions. The 
ratio of benign to malignant accounted for 1.3:1. This data 
clearly shows that benign lesions were more common than 
their malignant counterparts in our environment. This 
finding is in keeping with previous reports by Ozumba et al. 
where benign lesions were more common than malignant 
lesions.[6,7] However our report is at variance with reports 
by some researchers from other parts of the world where 
malignant cervical lesions were more common than benign 
lesions. The reason for this variation may be partly due 
to differences in geo‑ethnic variation, inadequate cancer 
register in our locality and the fact that most cancer patients 
seek alternative/trado‑medical therapy hence most cancer 
cases are not reported.
The peak age range of non‑neoplastic cervical lesions was 
40‑49 years accounting for 33.7%. This finding is similar 
to previous reports from Ile‑Ife where its peak age of 
40‑49 years accounting for 34.7%. Our findings have shown 
that among the non‑neoplastic cervical lesions biopsied, 
59.8% were associated with features of cervicitis. Thus, it 
constitutes the highest percentage of non‑neoplastic cervical 
lesions in our environment. This report again is similar to 
previous studies by researchers where cervicitis accounted 
for 80% and 98% respectively.[1,8] However our findings are 
lower than these reported values. The reason attributed to 
this is that most cases in our environment go unreported. 
In addition, it is also important to note that most cases 
are treated empirically by physicians or by self‑medication. 
Therefore only few difficult cases would present at the 
gynecological clinic for proper evaluation when symptoms 
are recurrent and or persistence.
In this study, chronic non‑specific cervicitis accounted for 
72.7% of all cervicitis. This report is similar to previous work 
done by Omoniyi‑Esan et al. where chronic non‑specific 
cervicitis accounted for 82% of all non‑neoplastic 
lesions.[1] The reason for this is that the cervix is a gateway 
for reproduction and sexual intercourse and hence can be 
prone to STIs and UTIs during intercourse, conception, 
pregnancy, delivery and post‑partum. Studies have showed 
that sexually transmitted infections implicated in cervicitis 
include Neisseria gonorrhoeae, chlamydia trachomatis and 
staphylococcus aureus in women of developing countries. 
Thus it accounted for 10%, 7.7% and 7% in Kenya, Ghana 
and Gambia respectively.[9,10,11] Reports have it that the 
frequency of chronic cervicitis in sexually active adolescent 
girls is 10.5% in Nigeria.[1] In our study chronic non‑specific 
cervicitis occurred between the age range of 20‑79 years 
with a peak incidence at the 5th decades of life. No case was 
seen before menarche. This is similar to previous reports 
by Craig and Lowe.[12] The reason being that that most 
girls are not sexually active before menarche. However 
in this study chronic cervicitis is a common phenomenon 
in post‑menopausal women. This finding also corroborate 
previous reports by other researchers.[1,12] The reasons for 
this are linked to sexual activities, reduction in immunity, 
use of replacement hormone therapy.
Studies have shown that HPV cervicitis is on the increase 
worldwide.[13] Modern diagnostic techniques including 
polymerase chain reactions, HPV genotyping, In situ 
hybridization and molecular studies have increased the 
specificity of this diagnosis. The frequency of HPV cervicitis, 
particularly high risk biotypes that usually result in cervical 
cancer varies world‑wide.[13] The prevalence of chronic 
cervicitis with koilocytic changes of HPV infection in this 
study accounted for 14.6% of all cervicitis. This occurred in 
sexually active women between the ages of 30 to 59 years 
in this study. Our finding is in keeping with reports from 
Argentina where HPV accounted for 15% of sexually active 
women between the ages of 15 to 65 years.[14] Nevertheless, 
this finding is slightly at variance with the prevalence of 
HPV positivity of 26.3% in Ibadan.[15] The reasons for this 
variations is attributed to the different methods used. Other 
studies from Africa also supported the high prevalence of 
HPV cervicitis in Sub‑Saharan Africa.[15] Studies done 
in Uganda reported 17% prevalence of HPV cervicitis. 
Although the method used (Hybrid capture assay II) is 
more sensitive.[15]
In this study acute cervicitis accounted 12.7% and 7.6% of 
all cervicitis and non‑neoplastic cervical lesions respectively. 
This is at variance with other reports where it accounted for 
2% of non‑neoplastic cervical lesions.[1,16] The reason for this 
discrepancy cannot be ascertained although acute cervicitis 
could result from post‑abortal sepsis, post‑partum infections, 
acute urethritis and primary cervical infections resulting 
from the use of tampons. Most cases are treated clinically 
because of its acute discomfort nature of symptoms.
No case of TB cervicitis was seen in this study. This finding 
is not strange. The reason been that TB is an extremely rare 
finding accounting for 0.1% to 0.6% of cases world‑wide 
and it normally affect the upper genital tracts mainly the 
endometrium and fallopian tubes.[16]
Our findings showed that endocervical polyps accounted 
for 16.3% of non‑neoplastic cervical lesions and the peak 
age range was in the 5th decade. This is similar to reports 
where cervical polyps were more commonly seen in the 
reproductive age especially after 40 years of age.[2,17,18] Our 
finding also show that ectropion accounted for 11.9% of 
non‑neoplastic cervical lesions. This is a physiological 
432 Nigerian Journal of Clinical Practice • Oct-Dec 2013 • Vol 16 • Issue 4
Nwachokor and Forae: Non‑neoplastic cervical lesions
change that cut across all age group and is a common 
microscopic finding and is in keeping with previous report 
by Pallipady.[2] Endocervical hyperplasia was a less common 
finding which accounted for 4% of non‑neoplastic cervical 
lesions with prevalence in the 5th decades of and is usually 
an incidental finding. Our findings are similar to reports 
by Pallipady et al. where this lesion was seen in 4.3% of 
non‑neoplastic cervical biopsies.[2,18]
Conclusion
In this study, cervicitis including HPV cervicitis was the most 
common non‑neoplastic cervical lesions. This constitutes a 
scourge of morbidity and mortality if not properly diagnosed 
and managed. Adequate cervical screening with follow up 
histological biopsies is a relevant tool in diagnosing them 
to enhance early detection of premalignant and malignant 
cervical lesions.
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